As strengths, we show an easy, cheap synthetic protocol to generate a novel chalcone that has strong cytotoxicity and selectivity in vitro against different types of cancers, has low toxicity in vivo, and has good pharmacokinetic properties with a possible binding capability to MDM2 protein. Here, MDM2 is linked to cancer.